Recent news on Gynazole 1

KV Pharmaceutical pays $150 million for estrogen-replacement drug  -  Mar 31, 2007
St. Louis Post-Dispatch,These include Prima­Care prenatal vitamins and Gynazole-1 treatment for yeast infections. "EvaMist is a great strategic fit with our Ther-Rx women's health

KV Pharmaceutical Reports Preliminary Record Revenues for Fiscal ...  -  Feb 7, 2007
PR Newswire (press release),During the third quarter, the anti-infective products, Clindesse(R) and Gynazole-1(R) contributed $12.9 million of net sales. Year-to-date, revenues for

KV Pharmaceutical Company Reports Preliminary Record Revenues for ...  Nov 6, 2006
For the second quarter of fiscal 2007, Gynazole-1(R) contributed $6.1 million in revenues, an increase of 56% compared to the $3.9 million in revenues reported ... -MSN Money Branded drug unit drives KV sales growth  Nov 8, 2006
The company's Ther-Rx unit — which sells branded drugs including Gynazole-1, Clindesse and PrimaCare women's health products — reported second-quarter ... -St. Louis Post-Dispatch, KV Pharmaceutical Company Reports Fiscal 2007 First Quarter ...  Aug 8, 2006
For the first quarter of fiscal 2007, the Company's anti-infective products, Gynazole-1® and Clindesse(TM), reported net sales of $7.3 million and $5.3 million ... -Yahoo! News



Hungary Richter grants exclusive marketing rights to KV ...  Feb 14, 2006
Richter has been a terrific partner as demonstrated by the international licensing of our two NDA approved anti-infective products, Gynazole-1® and more ... - Portfolio.hu,

KV Pharmaceutical Reports Record Revenues for Fiscal 2006 Third ...  Feb 7, 2006
Ther-Rx Revenues The Company's two unique, single-dose treatments for vaginal yeast infections and bacterial vaginosis (BV); respectively, Gynazole-1(R) and ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional